-
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
-
TransMedics Reports Third Quarter 2025 Financial Results
-
TransMedics partners with Mercedes-Benz for organ transport fleet in Italy
-
TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy
-
TransMedics gets FDA approval to start heart preservation trial
-
TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
-
TransMedics Reports Second Quarter 2025 Financial Results
-
TransMedics Reports First Quarter 2025 Financial Results
-
TransMedics Reports Fourth Quarter and Full Year 2024 Financial Results
-
TransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report
-
TransMedics Group (TMDX) Appoints Gerardo Hernandez as CFO, Issues 2024 Financial Outlook Update
-
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
-
TransMedics Reports Third Quarter 2024 Financial Results
-
TransMedics Reports Second Quarter 2024 Financial Results
-
TransMedics Reports First Quarter 2024 Financial Results
-
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
-
TransMedics Reports Third Quarter 2023 Financial Results
-
TransMedics Reports Second Quarter 2023 Financial Results
-
TransMedics Reports First Quarter 2023 Financial Results
-
TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
-
TransMedics Reports Third Quarter 2022 Financial Results
-
TransMedics Reports Second Quarter 2022 Financial Results
-
TransMedics Reports First Quarter 2022 Financial Results
-
TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results

